Apimeds Pharmaceuticals US Inc APUS
$4.84 $0.45 (10.25%) 1D
Last Updated: Aug 21, 12:00 AM·XASE
Pricing for US stocks is delayed by 24 hours
APUS Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Apimeds Pharmaceuticals US Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Apimeds Pharmaceuticals US Inc. Stock Analysis APUS
United States Health Care Nano Cap Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
Apimeds Pharmaceuticals US Inc (APUS) Chart
Financial Metrics & Statements of Apimeds Pharmaceuticals US Inc (APUS)
FAQ's for Apimeds Pharmaceuticals US Inc (APUS)
- As of August 2026, Apimeds Pharmaceuticals US Inc APUS is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Apimeds Pharmaceuticals US Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Apimeds Pharmaceuticals US Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Apimeds Pharmaceuticals US Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Apimeds Pharmaceuticals US Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Apimeds Pharmaceuticals US Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Apimeds Pharmaceuticals US Inc (APUS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
